Ariston Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the acquisition, clinical development and rapid commercialization of human therapeutics in the Neurology area.
The Company is currently developing three clinical-stage compounds for application in four clinical indications. Prototypes of each product have shown evidence of efficacy and safety in previous clinical studies. Ariston intends to develop specialty sales and marketing capabilities to launch some of these products in the US market.